Isofol Medical AB (ISOFOL) — Cash Flow-to-Debt Ratio
Isofol Medical AB (ISOFOL) has a Cash Flow-to-Debt Ratio of -0.50x as of September 2025, meaning its operating cash flow of Skr-10.78 Million could theoretically repay -1% of its total liabilities (Skr21.51 Million) in one year. Explore ISOFOL cash flow metrics to assess how effectively this company generates cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Isofol Medical AB Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Isofol Medical AB across 11 annual periods. Also explore how large is Isofol Medical AB's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Isofol Medical AB (2015–2025)
Year-by-year debt coverage analysis for Isofol Medical AB. For market capitalisation and broader financial context, see Isofol Medical AB (ISOFOL) total market value.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.41x | Skr-51.94 Million | Skr21.52 Million | ▼ -17.6% |
| 2024 | -2.05x | Skr-41.99 Million | Skr20.47 Million | ▲ +25.2% |
| 2023 | -2.74x | Skr-52.54 Million | Skr19.16 Million | ▲ +21.1% |
| 2022 | -3.47x | Skr-190.97 Million | Skr54.99 Million | ▼ -53.2% |
| 2021 | -2.27x | Skr-188.43 Million | Skr83.13 Million | ▼ -15.4% |
| 2020 | -1.96x | Skr-160.27 Million | Skr81.56 Million | ▲ +44.5% |
| 2019 | -3.54x | Skr-147.21 Million | Skr41.56 Million | ▲ +9.8% |
| 2018 | -3.93x | Skr-92.46 Million | Skr23.54 Million | ▼ -15.7% |
| 2017 | -3.40x | Skr-61.94 Million | Skr18.24 Million | ▼ -0.2% |
| 2016 | -3.39x | Skr-56.90 Million | Skr16.79 Million | ▲ +22.1% |
| 2015 | -4.35x | Skr-36.77 Million | Skr8.46 Million | — |